NYSE · Technology
Zepp Health Corp (ZEPP)
As-reported financials and recent SEC filings for Zepp Health Corp, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$258.9M
Net income
$-40.1M
Net margin
-15.5%
Diluted EPS
$-0.16
ROE
-18.7%
P/E (TTM)
—
Market cap
$65.8M
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $258.9M | $182.6M | $2.50B | $4.14B | $6.25B |
| Gross profit | $99.2M | $70.2M | $2.23B | $3.65B | $1.31B |
| Operating income | $-29.2M | $-47.3M | $-30.4M | $-61.9M | $93.9M |
| Net income | $-40.1M | $-75.7M | $-31.0M | $-43.2M | $137.8M |
| Diluted EPS | $-0.16 | $-0.29 | $-0.13 | $-0.18 | $0.52 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-26
View on EDGAR →SCHEDULE 13G2026-06-26
View on EDGAR →6-K2026-06-09
View on EDGAR →SCHEDULE 13G/A2026-05-06
View on EDGAR →20-F2026-04-24
View on EDGAR →32026-03-17
View on EDGAR →32026-03-17
View on EDGAR →32026-03-16
View on EDGAR →Go deeper on ZEPP
Search Zepp Health Corp’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.